Gaurav Aggarwal, M.D.
Compensation Committee, Strategic Committee (Chair)
Gaurav Aggarwal, M.D. has served as a director of Geron since November 2023.
Background
Dr. Aggarwal has been an investor in the life sciences sector for more than 20 years. Most recently he was Managing Director of the global investment firm, Vivo Capital LLC, from 2016 to 2023, and Chief Investment Officer of its U.S. public investment fund from 2021 to 2023. Dr. Aggarwal previously served as the Chief Business Officer of Ocera Therapeutics, Inc., a publicly traded clinical stage company developing therapies for orphan liver conditions, from April 2014 through October 2016, as Managing Director of Investor Growth Capital from January 2013 through December 2013, and as a General Partner at Panorama Capital, L.P., a venture capital fund, from August 2006 through December 2012. Earlier in his career, Dr. Aggarwal was an associate with JP Morgan Partners, LLC, a private equity division of JP Morgan Chase & Co.
Dr. Aggarwal has served on the board of Unicycive Therapeutics, Inc., since March 2023, and previously served on the board of directors of Sierra Oncology, Inc., (acquired by GlaxoSmithKline plc), Hyperion Therapeutics, Inc., (acquired by Horizon Pharma plc), and on several privately held biopharmaceutical companies. Dr. Aggarwal received his B.S. in Agricultural Economics from Cornell University and his M.D. from Columbia University, College of Physicians & Surgeons.